Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus

Journal of Immunology

Volumn 164, Issue 4, 2000, Pages 1820-1828

  Sangster, Mark Y ^a   Topham, David J ^a,c   D'Costa, Sybil ^a   Cardin, Rhonda D ^a,d   Marion, Tony N ^b   Myers, Linda K ^b   Doherty, Peter C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES VIRUS; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0034651584     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.4.1820     Document Type: Article

References (77)

1. Blaskovic, D., M. Stancekova, J. Svobodova, and J. Mistrikova. 1980. Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol. 24:468.
2. Virgin, H. W., P. Latreille, P. Wamsley, K. Hallsworth, K. E. Weck, A. J. Dal Canto, and S. H. Speck. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894.
3. Simas, J. P., and S. Efstathiou. 1998. Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol. 6:276.
4. Sunil-Chandra, N. P., S. Efstathiou, J. Arno, and A. A. Nash. 1992. Virological and pathological features of mice infected with murine gammaherpesvirus 68. J. Gen. Virol. 73:2347.
5. + T cells. J. Exp. Med. 184:863.
6. Sunil-Chandra, N. P., S. Efstathiou, and A. A. Nash. 1992. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73:3275.
7. Weck, K. E., S. S. Kim, H. W. Virgin IV, and S. H. Speck. 1999, Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J. Virol 73:3273.
8. Ehtisham, S., N. P. Sunil-Chandra, and A. A. Nash. 1993. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J. Virol. 67:5247.
9. Usherwood, E. J., A. J. Ross, D. J. Allen, and A. A. Nash. 1996. Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. J. Gen. Virol. 77:627.
10. Tripp, R. A., A. M. Hamilton-Easton, R. D. Cardin, P. Nguyen, F. G. Behm, D. L. Woodland, P. C. Doherty, and M. A. Blackman. 1997. Pathogenesis of an infectious mononucleosis-like disease induced by a murine γ-herpesvirus: role for a viral superantigen? J. Exp. Med. 185:1641.
11. Hamilton-Easton, A. M., J. P. Christensen, and P. C. Doherty. 1999. Turnover of T cells in murine gammaherpesvirus 68-infected mice. J. Virol 73:7866.
12. + T cells, and B cells in an infectious mononucleosis-like syndrome. J. Virol. 73: 9650.
13. + T cell-mediated control of a γ-herpesvirus in B cell-deficient mice is mediated by IFN-γ. Proc. Natl. Acad. Sci. USA 96:5115.
14. Usherwood. E. J., J. P. Stewart, K. Robertson, D. J. Allen, and A. A. Nash. 1996. Absense of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J. Gen. Virol. 77:2819.
15. + T cells. J. Gen. Virol. 80:477.
16. Stewart, J. P., E. J. Usherwood, A. Ross, H. Dyson, and T. Nash. 1998. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J. Exp. Med. 187:1941.
17. Khyatti, M., P. C. Patel, I. Stefanescu, and J. Menezes. 1991. Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity. J. Virol. 65:996.
18. Stevenson, P. G., and P. C. Doherty. 1998. Kinetic analysis of the specific host response to a murine gammaherpesvirus. J. Virol. 72:943.
19. Stevenson, P. G., and P. C. Doherty. 1999. Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J. Virol. 73:1075.
20. Sangster, M. Y., X. Y. Mo, R. Sealy, and C. Coleclough. 1997. Matching antibody class with pathogen type and portal of entry: cognate mechanisms regulate local isotype expression patterns in lymph nodes draining the respiratory tract of mice inoculated with respiratory viruses, according to virus replication competence and site of inoculation. J. Immunol. 159:1893.
21. Bradford, M. M. 1976. A rapid and sensitive method for the quamitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
22. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Köhler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339.
23. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739.
24. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliot, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunol. 1:423.
25. + T cells in major histocompatibility complex class 11-deficient mice. Science 253:1417.
26. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane axon of the immunoglobulin mu chain gene. Nature 350:423.
27. + T cell response and memory. J. Immunol. 161:4530.
28. 2,-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. J. Immunol 153:1246.
29. Coutelier, J.-P., J. T. M. van der Logt, F. W. A. Heessen, A. Vink, and J. Van Snick. 1988. Virally induced modulation of murine IgG antibody subclasses. J. Exp. Med. 168:2373.
30. Myers, L. K., J. M. Seyer, J. M. Stuart, and A. H. Kang. 1997. Suppression of murine collagen-induced arthritis by nasal administration of collagen. Immunology 90:161.
31. 1 mice are clonally heterogeneous, but the majority share a common idiotype. J. Immunol. 128:668.
32. Schibeci, A., A. W. Wade, W. T. Depew, and M. R. Szewczuk. 1986. Analysis of serum antibody repertoires by isoelectric focusing and capillary blotting onto nitrocellulose paper. J. Immunol. Meth. 89:201.
33. Tilney, N. L. 1971. Patterns of lymphatic drainage in the adult laboratory rat. J. Anat. 109:369.
34. Sarawar, S. R., R. D. Cardin, J. W. Brooks, M. Mehrpooya, A.-M. Hamilton-Easton, X. Y. Mo, and P. C. Doherty. 1997. Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvinis-68. J. Virol. 71: 3916.
35. + T-cell response to a persistent gammaherpesvirus. J. Virol. 73: 4279.
36. Slifka, M. K., R. Antia, J. K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8:363.
37. Hyland, L., M. Sangster, R. Sealy, and C. Coleclough. 1994. Respiratory virus infection of mice provokes a permanent humoral immune response. J. Virol. 68:6083.
38. Sangster, M., L. Hyland, R. Sealy, and C. Coleclough. 1995. Distinctive kinetics of the antibody-forming cell response to Sendai virus infection of mice in different anatomical compartments. Virology 207:287.
39. Slifka, M. K., M. Matloubian, and R. Ahmed. 1995. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69:1895.
40. Blaser, K., and H. N. Eisen. 1978. λ2 light chains in normal mouse immunoglobulins. Proc. Natl. Acad. Sci. USA 75:1495.
41. + T cells and CD40. Virology 240:12.
42. Nguyen, L., D. M. Knipe, and R. W. Finberg. 1994. Mechanism of virus-induced Ig subclass shifts. J. Immunol. 152:478.
43. Sarawar, S. R., R. D. Cardin, J. W. Brooks, M. Mehrpooya, R. A. Tripp, and P. C. Doherty. 1996. Cytokine production in the immune response to murine gammaherpesvirus 68. J. Virol. 70:3264.
44. Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1.
45. Snapper C. M., F. Rosas, M. A. Moorman, L. Jin, K. Shanebeck, D. M. Klinman, M. R. Kehry, J. J. Mond, and C. R. Maliszewski. 1996. IFN-γ is a potent inducer of Ig secretion by sort-purified murine B cells activated through the mlg, but not the CD40, signaling pathway. Int. Immunol. 8:877.
46. Snapper, C. M., and W. E. Paul. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944.
47. Durie, F. H., T. M. Foy, S. R. Masters, J. D. Laman, and R. J. Noelle. 1994. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15:406.
48. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111.
49. + T cell responses in mice lacking MHC class II molecules specifically on B cells. Ear. J. Immunol. 28:3763.
50. Rosén, A., P. Gergely, M. Jondal, and G. Klein. 1977. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature 267:52.
51. Hutt-Fletcher, L. M., N. Balachandran, and M. H. Elkins. 1983. B cell activation by cytomegalovirus. J. Exp.Med. 158:2171.
52. Klinman, D. M., and A. D. Steinberg. 1987. Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Mett. 165:1755.
53. Kizaka, S., G. Goodman-Snitkoff, and J. J. McSharry. 1983. Sendai virus glycoproteins are T cell-dependent B cell mitogens. Infect. Immun. 40:592.
54. Jones, P. D., and G. L. Ada. 1986. Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection. J. Virol. 60:614.
55. Bachmann, M. F., T. M. Kündig, B. Odermatt, H. Hengartner, and R. M. Zinkernagel. 1994. Free circulation of memory B cells versus antigen-dependent differentiation to antibody-forming cells. J. Immunol. 153:3386.
56. Coutelier, J.-P., J. T. M. van der Logt, F. W. A. Heessen, G. Warnier, and J. Van Snick. 1987. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 165:64.
57. Rott, O., and E. Cash. 1994. Influenza virus hemagglutinin induces differentiation of mature resting B cells and growth arrest of immature WEHI-231 lymphoma cells. J. Immunol. 152:5381.
58. Mega, J., J. R. McGhee, and H. Kiyono. 1992. Cytokine- and Ig-producing cells in mucosal effector tissues: analysis of IL-5-and TFN-γ-producing T cells, T cell receptor expressior, and IgA plasma cells from mouse salivary gland-associated tissues. J. Immunol. 148:2030.
59. Tamura, S., T. Iwasaki, A. H. Thompson, H. Asanuma, Z. Chen, Y. Suzuki, C. Aizawa, and T. Kurata. 1998. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza infection. J. Gen. Virol. 79:291.
60. Kuper, C. F., P. J. Koornstra, D. M. H. Hameleers, J. Biewenga, B. J. Spit, A. M. Duijvestijn, P. J. C. van Breda Vriesman, and T. Sminia. 1992. The role of nasopharyngeal lymphoid tissue. Immunol. Today 13:219.
61. Faulkner, O. C., S. R. Burrows, R. Khanna, D. J. Moss, A. G. Bird, and D. H. Crawford. 1999. X-linked agammaglobulinernia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J. Virol. 73: 1555.
62. Thorley-Lawson, D. A., E. M. Miyashita, and G. Khan. 1996. Epstein-Barr virus and the B cell: that's all it takes. Trends Microbiol. 4:204.
63. Benner, R., F. Meima, G. M. van der Meulen, and W. B. van der Muiswinkel. 1974. Antibody formation in mouse bone marrow. I. Evidence for the development of plaque-forming cells in situ. Immunology 26:247.
64. Hill, S. W. 1976. Distribution of plaque-forming cells in the mouse for a protein antigen: evidence for highly active parathymic lymph nodes following intraperitoneal injection of hen lysozynie. Immunology 30:895.
65. Takahashi, Y., P. R. Dutta, D. M. Cerasoli, and G. Kelsoe. 1998. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection. J Exp. Med. 187:885.
66. Smith, K. G. C., A. Light, G. J. V. Nossal, and D. M. Tarlinton. 1997. The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary response. EMBO J. 16:2996.
67. Clark, E. A., and J. A. Ledbetter. 1994. How B and T cells talk to each other. Nature 367:425.
68. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune response in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167.
69. Held, W., H. Acha-Orbea, H. R. MacDonald, and G. A. Waanders. 1994. Superantigens and retroviral infection: insights from mouse mammary tumor virus. Immunol. Today 15:184.
70. Brawn, N. A., C. Liu, C. R. Garcia, Y.-F. Wang, A. Griffith, R. S. Sparkes, and K. L. Calame. 1986. Clonal origins of lymphoproliferative disease induced by Epstein-Barr virus. J. Virol. 58:975.
71. Anderson, P., and H. K. Anderson. 1975. Smooth-muscle antibodies and other tissue antibodies in cytomegalovirus infection. Clin. Exp. Immunol. 22:22.
72. Garzelli, C., F. E. Taub, J. E. Scharff, B. S. Prabhakar, F. Ginsberg-Fellner, and A. L. Notkins. 1984. Epstein-Barr virus-transformed lymphocytes produce monoclonal autoantibodies that react with antigens in multiple organs. J. Virol. 52:722.
73. Farrell, H. E., and G. R. Shellam. 1990. Characterization of neutralizing monoclonal antibodies to murine cytomegalovirus. J. Gen. Virol. 71:655.
74. Lawson, C. M., H. L. O'Donoghue, H. E. Farrell, G. R. Shellam, and W. D. Reed. 1991. Murine anti-cytomegalovirus monoclonal antibodies with auloreactivity. Immunology 72:426.
75. Bartholomaeus, W. N., H. O'Donoghue, D. Foti, C. M. Lawson, G. R. Shellam, and W. D. Reed. 1988. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology 64:397.
76. Price, P., S. D. Olver, A. E. Gibbons, and G. R. Shellam. 1993. B-cell activation following murine cytomegalovirus infection: implications for autoimmunity. Immunology 78:14.
77. Rekvig, O. P., F. Fredriksen, B. Brannsether, U. Moens, A. Sundsfjord, and T. Traavik. 1992. Antibodies to eukaryotic, including autologous, native DNA are produced during BK virus infection, but not after immunization with non-infectious BK DNA. Scand. J. Immunol. 36:487.